share_log

Short Interest in Artemis Therapeutics Inc. (OTCMKTS:ATMS) Drops By 15.4%

Short Interest in Artemis Therapeutics Inc. (OTCMKTS:ATMS) Drops By 15.4%

空頭股數在Artemis治療公司(場外交易代碼：ATMS)下跌15.4%
Defense World ·  2022/08/15 15:21

Artemis Therapeutics Inc. (OTCMKTS:ATMS – Get Rating) saw a significant decrease in short interest in July. As of July 31st, there was short interest totalling 1,100 shares, a decrease of 15.4% from the July 15th total of 1,300 shares. Based on an average daily trading volume, of 500 shares, the short-interest ratio is presently 2.2 days.

Artemis治療公司(OTCMKTS：ATMS-GET Rating)7月份空頭股數使用量大幅下降。截至7月31日，空頭股數共有1,100股，較7月15日的1,300股減少15.4%。以日均成交量500股計算，目前短息比為2.2天。

Artemis Therapeutics Trading Down 49.4 %

Artemis治療公司股價下跌49.4%

Shares of OTCMKTS:ATMS opened at $0.91 on Monday. The company has a fifty day moving average of $3.34 and a 200-day moving average of $2.19. Artemis Therapeutics has a 52-week low of $0.55 and a 52-week high of $5.00.

OTCMKTS：ATM機週一開盤報0.91美元。該公司的50日移動均線切入位在3.34美元，200日移動均線切入位在2.19美元。Artemis Treeutics的52周低點為0.55美元，52周高位為5.00美元。

Get
到達
Artemis Therapeutics
Artemis治療公司
alerts:
警報：

Artemis Therapeutics (OTCMKTS:ATMS – Get Rating) last posted its quarterly earnings data on Monday, May 23rd. The company reported ($0.01) earnings per share for the quarter.

Artemis治療公司(OTCMKTS：ATMS-GET Rating)最近一次公佈季度收益數據是在5月23日星期一。該公司公佈了本季度每股收益(0.01美元)。

About Artemis Therapeutics

關於Artemis Treateutics

(Get Rating)
(獲取評級)

Artemis Therapeutics Inc does not have significant operations. Previously, it was involved in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc is a subsidiary of Tonak Ltd.

Artemis治療公司沒有重大的手術。此前，它參與了嚴重和危及生命的傳染病預防和治療試劑的開發。該公司總部設在紐約，紐約州。Artemis治療公司是Tonak有限公司的子公司。

Further Reading

進一步閲讀

  • Get a free copy of the StockNews.com research report on Artemis Therapeutics (ATMS)
  • Here is a Simple 4 Stock Portfolio that Can Outperform the Market
  • Is AMC Entertainment Pulling a Fast One on the APEs?
  • Here's How the Inflation Reduction Act Energizes Power Stock
  • 2 Important Retail Stock Battles to Watch
  • MarketBeat: Week in Review 8/8 – 8/12
  • 免費獲取StockNews.com關於Artemis治療(ATMS)的研究報告
  • 以下是一個簡單的4只股票投資組合，它可以跑贏大盤
  • AMC娛樂公司是在對猩猩採取快速行動嗎？
  • 以下是《降低通脹法案》如何提振電力庫存
  • 值得關注的兩場重要的零售股大戰
  • MarketBeat：回顧中的一週2012-8-8

Receive News & Ratings for Artemis Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Artemis Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

接受Artemis治療日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Artemis治療公司和相關公司的最新新聞和分析師評級的每日簡要摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論